Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-dose contrast-enhanced MRI in multiple sclerosis

T Koudriavtseva1, C Pozzilli, C Di Biasi

  • 1Department of Neurosciences, University of Rome, La Sapienza, Italy.

Neuroradiology
|May 1, 1996
PubMed
Summary

High-dose gadolinium-HP-DO3A contrast agent detected more active lesions in multiple sclerosis (MS) patients than standard gadolinium-DTPA. This enhanced detection improves assessment of disease activity and treatment efficacy in MS clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiome depletion rejuvenates the aging brain.

bioRxiv : the preprint server for biology·2026
Same author

Perioperative Predictors of Recurrency in Chronic Subdural Hematoma: A Retrospective Analysis of 150 Consecutive Cases.

World neurosurgery·2025
Same author

Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome project.

Journal of neurology·2025
Same author

Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors.

Multiple sclerosis and related disorders·2023
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Initial oak regeneration responses to experimental warming along microclimatic and macroclimatic gradients.

Plant biology (Stuttgart, Germany)·2022

Area of Science:

  • Radiology
  • Neurology
  • Medical Imaging

Background:

  • Contrast-enhanced magnetic resonance imaging (MRI) is crucial for evaluating disease activity in multiple sclerosis (MS).
  • It serves as a potential outcome measure for assessing therapeutic efficacy in clinical trials.
  • Comparing different contrast agents is essential for optimizing diagnostic sensitivity.

Purpose of the Study:

  • To compare the sensitivity of a high dose of gadolinium-HP-DO3A against a standard dose of gadolinium-DTPA.
  • To evaluate the impact of contrast agent dose on detecting active lesions in relapsing-remitting MS.

Main Methods:

  • 16 patients with relapsing-remitting MS in the acute phase underwent two MRI scans within 48 hours.
  • The first MRI used a standard dose of gadolinium-DTPA (0.1 mmol/kg).

Related Experiment Videos

  • The second MRI used an experimental high dose of gadolinium-HP-DO3A (0.3 mmol/kg).

    • Main Results:

    • The high-dose gadolinium-HP-DO3A study identified significantly more enhancing lesions (56) compared to the standard-dose gadolinium-DTPA (38).
    • This difference was particularly notable for infratentorial and smaller lesions.
    • A marked improvement in lesion visibility and delineation was observed with the higher dose contrast agent.

    Conclusions:

    • High-dose gadolinium-HP-DO3A demonstrates superior sensitivity in detecting active lesions in MS compared to standard gadolinium-DTPA.
    • This enhanced sensitivity can improve the assessment of MS disease activity.
    • Gadolinium-HP-DO3A may offer a more effective tool for MS clinical trials.